THOMPSON SIEGEL & WALMSLEY LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 1 filers reported holding ANI PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,279
-31.9%
228,707
-36.9%
0.22%
-29.3%
Q2 2023$19,502
+24.7%
362,291
-8.0%
0.31%
+22.9%
Q1 2023$15,641
-6.4%
393,789
-5.2%
0.25%
-6.3%
Q4 2022$16,707
-99.9%
415,280
-0.2%
0.27%
+16.9%
Q3 2022$13,369,000
+3.4%
415,962
-4.6%
0.23%
+11.1%
Q2 2022$12,932,000
+8.5%
435,873
+2.8%
0.21%
+22.4%
Q1 2022$11,921,000
-7.5%
424,087
+51.7%
0.17%
-4.0%
Q4 2021$12,882,000
-12.9%
279,554
-37.9%
0.18%
-16.9%
Q3 2021$14,786,000
+10.9%
450,504
+18.4%
0.21%
+16.4%
Q2 2021$13,336,000
+12.3%
380,474
+15.8%
0.18%
+8.3%
Q1 2021$11,873,000
+22.8%
328,539
-1.3%
0.17%
+9.0%
Q4 2020$9,665,000
+1.7%
332,807
-1.3%
0.16%
-15.8%
Q3 2020$9,508,000
-1.7%
337,038
+12.7%
0.18%
-5.6%
Q2 2020$9,668,000
+5905.0%
298,934
+7483.3%
0.20%
+4775.0%
Q1 2020$161,0003,9420.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders